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Prevalence of the Metabolic 
Syndrome and its determinants 
among Nepalese adults: Findings 
from a nationally representative 
cross-sectional study
Suresh Mehata1, Nipun Shrestha  2, Ranju Kumari Mehta3, Bihungum Bista3, 
Achyut Raj Pandey3 & Shiva Raj Mishra4,5
Metabolic syndrome (MetS) increases the risk of cardiovascular diseases and diabetes mellitus. 
This study is designed to assess the prevalence and determinants of MetS among Nepalese adults 
from a nationally representative study. This study is based on Stepwise Approach to Surveillance 
(STEPS) Survey from Nepal. This survey was done among 4200 adults aged 15–69 years from 210 
clusters selected proportionately across Nepal’s three ecological zones (Mountain, Hill and Terai). 
Subsequently, using systematic sampling, twenty households per cluster and one participant per 
household were selected. The overall prevalence of MetS is 15% and 16% according to Adult Treatment 
Panel III (ATP III) and International Diabetes Federation (IDF) criteria respectively. A triad of low HDL-C, 
abdominal obesity and high BP was the most prevalent (8.18%), followed by abdominal obesity, low 
HDL-C cholesterol and high triglycerides (8%). Less than two percent of participants had all the five 
components of the syndrome and 19% of participants had none. The prevalence steadily rose across 
the age group with adults aged 45–69 years having the highest prevalence (28–30%) and comparable 
prevalence across two definitions of MetS. A notably high burden for females, urban, hill or Terai 
resident were seen among other factors.
The inter-related cluster of cardio-metabolic risk factors comprising of elevated fasting glucose, elevated blood 
pressure, elevated triglycerides (TG), reduced high-density lipoprotein (HDL) and central obesity has been 
termed Metabolic syndrome (MetS) in the literature1. There is two fold increase in risk for cardiovascular disease 
and five fold increase in risk for type II diabetes in people with MetS compared to those without syndrome2,3. 
Hence treatment and prevention of MetS is of paramount importance as a means of lowering the risk of diabetes 
and cardiovascular disease (CVD).
There is large variation in global prevalence of MetS ranging from 7.1% to 41.6% across studies due to lack 
of consensus definition of MetS4–6. The most commonly used criteria are the International Diabetes Federation 
adopted in 2005 (IDF)7 and Adult Treatment Panel III (ATPIII) adopted in 20054. Although the mechanism of 
MetS has not been elucidated fully, various factors such as unhealthy diet, physical inactivity, urbanization and 
underlying genetic predisposition have been found to be associated with MetS8.
With rapid demographic and epidemiologic transition in Nepal, the burden of non-communicable diseases 
(NCDs), notably cardiovascular disease (CVD) has escalated to epidemic proportion9. A recent hospital based study 
conducted in a random sample of indoor patients from tertiary levels hospitals found that 31% of admitted patients 
suffer from NCDs; with cardiovascular disease and diabetes accounting for 40% and 12% of NCDs respectively10. 
This hospital based study might not reflect the true prevalence of NCDs at population level in Nepal as utilization of 
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health services remains poor and urban-centric. The absence of routine surveillance and registry system in Nepal has 
further made it challenging to precisely estimate the burden of MetS11. An earlier prevalence study limited to eastern 
region of Nepal found one in five Nepalese adults have MetS12. This is comparable to studies from neighboring South 
Asian countries like India, Pakistan and Bangladesh where nearly a third of population have MetS13,14. None of the 
studies conducted thus far assessed the attributing factors in occurrence of MetS in Nepal.
The unavailability of nationally representative prevalence estimates and factors attributing on MetS has hin-
dered the development of targeted strategies against MetS. A focus on individual components of MetS is a norm 
in routine practice, as well as the recently formed Multi-sectoral Action Plan of NCDs from Ministry of Health of 
Nepal addresses hypertension, diabetes, obesity and raised cholesterol separately while MetS is unaddressed giv-
ing the lack of evidence at population level. Hence, it is important to investigate the prevalence and determinants 
of MetS at entire-population level, using the nationally representative data. This is important for local planning, 
addressing the population burden via concerted actions on its determinants and targeting the high-risk groups.
Results
This secondary-analysis of the data provided by the nationally representive survey (STEPS Survey), provides the 
first nationally representative prevalence of MetS among adult population of Nepal. A total of 3729 participants 
aged 15 to 69 years were assessed for physical and biochemical parameters. The prevalence of metabolic syndrome 
is 15% and 16% according to ATP III and IDF criteria respectively. Overall, 21% of participants had had three or 
more risk factors. The most predominant component of MetS in this population was low HDL cholesterol (71%), 
followed by high blood pressure (26%) and raised triglycerides (25%). A significantly high prevalence of abdom-
inal obesity and low HDL cholesterol was observed among female participants; whereas raised triglycerides, 
fasting blood sugar and high blood pressure was observed among male participants (Table 1).
A triad of low HDL-C, abdominal obesity and high BP was the most prevalent constituting 8.2% of the total 
participants, followed by abdominal obesity, low HDL-C cholesterol and high triglycerides at 8% of participants. 
Less than two percent of participants had all the five components of the syndrome (Table 1). Only 19% of partic-
ipants had zero risk factors (Fig. 1).
Table 2 presents the independent effect of various covariates on the clustering of MetS components at the indi-
vidual level using multivariate Poisson regression. The age, education, caste/ethnicity, abnormal waist hip ratio, 
BMI and place of residence were independently associated with the number of MetS components. Moreover, 
the cumulative risk of having x number of MetS risk factors or more versus having fewer were 1.28 times higher 
among participants aged 30–44 years and 1.52 times higher among participants aged 45–69 years compared to 
15–29 years. The cumulative risks increased with increase in age and educational level. Participants those who 
resides in urban areas were 1.13 times more likely to have x or more risk factors compared to rural residence.
Table 3 presents prevalence of MetS assessed using ATP III and IDF criteria. The prevalence was higher among 
participants aged 45 to 69 years, those who do not have formal education, widowed/divorced/separated, belongs 
to religious minorities, those who resides in hilly region, and among urban dwellers. Likewise, the higher preva-
lence was also observed among participants who had abnormal waist hip ratio, and were obese [BMI ≥ 30 kg/m2]. 
The differences in the prevalence of the MetS using ATP III and IDF criteria can be demonstrated by data from 
the study. Although both the definition identified approximately 16% of the population as having the MetS, there 
was a large variability and only 10% of individuals met the criteria for both the definitions (Fig. 2).
Both sexes 
(N = 3729)
Male 
(N = 1190)
Female 
(N = 2539) P
Abdominal obesity* 27.47 18.03 36.49 <0.001
Raised triglycerides (TRI)ɫ 25.26 31.78 19.50 <0.001
Low HDL cholesterolǂ 70.72 61.22 79.29 <0.001
Raised fasting blood glucose§ 17.59 21.36 13.71 <0.001
High blood pressure¶ 26.28 30.84 20.18 <0.001
0 or <3 components 78.85 79.03 78.67 0.923
Low HDL + TRI + high BP 6.90 6.41 9.18 0.014
Low HDL + TRI + abdominal obesity 7.83 1.04 5.28 0.011
Low HDL + TRI + abdominal obesity + high BP 3.92 3.91 3.93 0.977
Low HDL + TRI + abdominal obesity + high BP + FG 1.30 0.96 1.64 0.007
Low HDL + abdominal obesity + high BP 8.18 6.85 9.45 0.010
Low HDL + abdominal obesity + FG 4.74 3.40 6.02 0.003
TRI + abdominal obesity + high BP + FG 1.82 1.72 1.92 0.647
Abdominal obesity + FG + High BP 3.62 3.71 3.52 0.768
Table 1. Frequency distribution of various combinations of components of metabolic syndrome among the 
participants (N = 3729). *Abdominal obesity (waist ≥90 cm in men or ≥80 cm in women). ɫRaised triglycerides 
(≥150 mg/dL or specific treatment for this lipid abnormality). ǂLow HDL cholesterol (<40 mg/dL in men; 
<50 mg/dL in women or specific treatment for this lipid abnormality). §Raised fasting blood glucose (≥100 mg/
dL or previously diagnosed type 2 diabetes). ¶High BP (systolic BP ≥130 or diastolic BP ≥85 mm Hg or 
treatment of previously diagnosed hypertension). BMI, body mass index; BP, blood pressure; HDL, high-density 
lipoprotein.
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In adjusted model, age, gender, abnormal waist hip ratio, BMI, ecological zone, place of residence were the 
significant predictor of MetS by both the criteria (Table 4).
Using IDF criteria, compared to participants aged 15–29 years, the higher odds of occurrence of MetS was 
observed among participation aged 30–44 years (AOR: 2.07; 95% CI: 1.31–3.25) and 45–69 years (AOR: 4.52; 
95% CI: 2.91–7.03). The odds of occurrence of MetS was significantly higher among female (AOR: 1.44; 95% CI: 
1.05–1.97) compared to male counterparts. Likewise, participants who had abnormal waist hip ratio had higher 
likelihood of MetS compared to normal (AOR: 8.18; 95% CI: 5.93–11.29), and the study also revealed that the 
higher risk of occurrence of MetS among overweight (AOR: 7.82; 95% CI: 5.78–10.78) and obese (AOR: 14.03; 
95% CI: 8.71–22.60) compared to those who had <25 kg/m2 BMI. Also, compared to participants who resides in 
mountains, the higher likelihood of occurrence among the residence who resides in Terai/the plain (AOR: 2.64; 
95% CI: 1.14–6.11) and hill (AOR: 2.41; 95% CI: 1.04–5.63). The higher odds of occurrence of MetS was observed 
among urban dwellers (AOR: 1.56; 95% CI: 1.14–2.13) compared to rural dwellers.
Discussion
This secondary-analysis of the data provided by the nationally represented survey (STEPS Survey), provides the 
first nationally representative estimates on prevalence, disaggregated by sub-groups, and factors attributed to 
MetS among adult population of Nepal. The overall prevalence of metabolic syndrome is 15% and 16% according 
to ATP III and IDF criteria respectively. Based on our findings, the Nepalese population appears to have a rela-
tively lower burden of MetS compared to overall burden of MetS in South Asia (ATPIII 26.1% and IDF 29.8%) 
reported by a systematic review15. A triad of central obesity, low HDL-C, and elevated BP was the most prevalent 
(8.2%) combination of CVD risk factors constituting the syndrome in this population. This was followed by a 
triad of CVD risk factors, namely central obesity, low HDL-C and elevated triglycerides found in 7.8% of the total 
participants. The most common MetS component was low HDL cholesterol.
In a multivariable analysis, the risk of MetS increased steadily with age: participants aged 45–69 were 7.08 
(ATP III) and 4.52 (IDF) times more likely to suffer from MetS than those who were in the age group 15–29 years. 
Similar findings were also seen with BMI: participants with BMI ≥ 30 kg/m2 were 9.44 (ATP III) and 14.03 (IDF) 
times more likely to suffer from MetS than those who had BMI < 25 kg/m2. The prevalence of MetS is higher in 
females compared to males in Nepal. The association with age, sex and BMI were consistent with previous studies 
from different countries13,16,17. People living in urban areas were twice more likely to develop MetS compared to 
rural residents. This might be due to sedentary lifestyles, dietary changes and stress in urban people.
The association of MetS with low physical activity was inconsistent with increased odds of 1.48 and decreased 
odds of 0.93 according to ATP III and IDP criteria respectively. However, some epidemiologic studies and uncon-
trolled trials have suggested that increased moderate-to-vigorous physical activity reduces the incidence or 
prevalence of the MetS18–21. Insufficient fruit and vegetable intake and cigarette smoking increased the odds of 
developing MetS in this study. Consumption of fruits and vegetables has been found to reduce diastolic blood 
pressure22 and risk of type II diabetes mellitus23 and may therefore reduce the risk of MetS. Current smoking was 
not-significantly associated with lower risk of MetS in our study. Existing evidence for association of MetS with 
cigarette smoking is inconsistent as well24–26. In our study, there was inconsistent evidence of association of alco-
hol intake and MetS with increased risk according to ATP III criteria and reduced risk according to IDP criteria. 
Various studies have shown that drinking alcohol is harmful at higher doses however, light to moderate doses is 
beneficial to health and reduces risk of coronary heart disease, diabetes, stroke and total mortality in adults27–29. A 
recent academic paper by international experts recommended lifestyle changes comprising of increased intake of 
fruits and vegetables, quitting smoking, moderate consumption of alcohol and physical activity to prevent MetS 
and improve cardio metabolic health30.
South Asians have a propensity towards less lean muscle mass and more visceral fat mass at a lower BMI 
and waist circumference compared to western population who tend to carry much of their weight in muscle 
and subcutaneous fat depots peripherally31,32. Thus South Asians with same body mass index are be at higher 
risk for metabolic syndrome compared to their western counterparts33. Moreover, comorbid diseases, including 
T2DM, occur at lower waist circumference in Asian adults34. Thus, ATP III might result in low prevalence figures 
Figure 1. Prevalence of various components of metabolic syndrome among participants aged 15–69 years.
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Age group Un-weighted
Mean number of
risk factors (95%CI) ARR*a P
15–29 831 1.28 (1.20–1.36) 1
30–44 1,410 1.85 (1.76–1.94) 1.28 (1.19–1.38) <0.001
45–69 1,488 2.14 (2.04–2.24) 1.52 (1.41–1.63) <0.001
Gender
Male 1,190 1.64 (1.54–1.74) 1
Female 2,539 1.71 (1.64–1.77) 1.03 (0.98–1.09) 0.247
Education
No formal schooling 1,662 1.77 (1.68–1.86) 1
Primary 917 1.67 (1.56–1.78) 1.03 (0.97–1.09) 0.325
Secondary 705 1.60 (1.47–1.74) 1.07 (1.00–1.16) 0.057
Higher 445 1.61 (1.49–1.74) 1.12 (1.03–1.23) 0.011
Marital status
Never married 299 1.24 (1.12–1.36) 1
Currently married 3,222 1.77 (1.70–1.84) 1.00 (0.90–1.12) 0.950
Divorced/Widowed/Separated 207 1.79 (1.58–2.00) 0.89 (0.78–1.03) 0.111
Caste/ethnicity
Dalits 317 1.76 (1.61–1.92) 1
Disadvantaged Janajatis 1,165 1.60 (1.51–1.69) 0.91 (0.82–1.01) 0.069
Disadvantaged non-Dalit Terai caste groups 296 1.50 (1.33–1.66) 0.88 (0.77–0.99) 0.036
Religious minorities 46 2.00 (1.53–2.47) 1.06 (0.83–1.34) 0.640
Relatively advantaged Janajatis 287 1.88 (1.61–2.15) 0.88 (0.77–1.00) 0.050
Upper caste groups 1,618 1.70 (1.59–1.80) 0.88 (0.80–0.98) 0.015
Ecological zone
Mountain 260 1.56 (1.30–1.82) 1
Hill 1,568 1.76 (1.64–1.88) 0.99 (0.83–1.17) 0.881
Terai 1,901 1.62 (1.54–1.70) 0.98 (0.83–1.15) 0.798
Place of residence
Rural 3,022 1.60 (1.53–1.67) 1
Urban 707 1.99 (1.81–2.16) 1.13 (1.05–1.21) 0.001
Current smoking
No 3,051 1.68 (1.61–1.76) 1
Yes 678 1.63 (1.51–1.74) 0.96 (0.89–1.03) 0.244
Harmful use of alcohol
No 3,663 1.67 (1.61–1.74) 1
Yes 66 1.70 (1.30–2.10) 1.10 (0.87–1.40) 0.417
Insufficient fruit and vegetable intake
No 43 1.78 (1.36–2.20) 1
Yes 3,686 1.67 (1.60–1.74) 1.07 (0.93–1.23) 0.330
Low physical activity
No 3,580 1.67 (1.60–1.73) 1
Yes 133 1.90 (1.64–2.16) 1.04 (0.94–1.16) 0.419
Abnormal waist hip ratio
No 1,056 1.29 (1.21–1.36) 1
Yes 2,673 1.94 (1.86–2.02) 1.35 (1.27–1.43) <0.001
BMI category
<25 2,773 1.42 (1.35–1.48) 1
25–30 763 2.50 (1.39–2.62) 1.51 (1.43–1.60) <0.001
>30 193 2.95 (2.72–3.19) 1.65 (1.52–1.78) <0.001
Total 3,729 1.67 (1.61–1.74)
Table 2. Mean number various components of metabolic syndrome and independent effects of covariates on 
metabolic syndrome components clustering in individuals. *The number of components of metabolic syndrome 
was the dependent variable. Each Relative Risk (RR) reflects the risk of having x or more components versus 
having fewer against the risk in the reference group. Hence, the Adjusted RR (ARR) represents the average 
effect of the covariate on the risk of having x number of components or more. aARR have been adjusted for all 
variables listed.
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Un-weighted ATP III IDF
Age group
15–29 831 4.71 6.06
30–44 1,410 18.3 19.43
45–69 1,488 29.97 28.27
P-value <0.001 <0.001
Gender
Male 1,190 15.30 13.42
Female 2,539 15.43 18.10
P-value 0.923 0.002
Level of education
No formal schooling 1,662 17.87 19.01
Primary 917 15.5 16.43
Secondary 705 15.39 14.31
Higher 445 11.05 11.80
P-value 0.021 <0.001
Marital status
Never married 299 3.79 3.19
Currently married 3,222 17.83 18.66
Divorced/Widowed/Separated 207 22.52 19.99
P-value <0.001 <0.001
Caste/ethnicity
Dalits 317 15.31 17.11
Disadvantaged Janajatis 1,165 13.29 13.05
Disadvantaged non-Dalit Terai caste groups 296 10.99 12.39
Religious minorities 46 25.25 16.32
Relatively advantaged Janajatis 287 23.04 23.70
Upper caste groups 1,618 16.12 16.83
P-value 0.007 0.020
Ecological zone
Mountain 260 12.45 5.56
Hill 1,568 19.09 18.36
Terai 1,901 12.65 14.96
P-value 0.002 0.001
Place of residence
Rural 3,022 13.42 13.75
Urban 707 23.42 24.36
P-value <0.001 <0.001
Current smoking
No 3,051 15.68 16.69
Yes 678 13.99 12.00
P-value 0.405 0.012
Harmful use of alcohol
No 3,663 15.25 15.96
Yes 66 20.72 9.23
P-value <0.458 0.196
Insufficient fruit and vegetable intake
No 43 12.84 17.83
Yes 3,686 15.39 15.79
P-value 0.665 0.786
Low physical activity
No 3,580 15.04 15.71
Yes 133 24.95 18.87
P-value 0.011 0.403
Abnormal waist hip ratio
No 1,056 7.3 2.94
Continued
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in Nepalese population due to use of non-specific cut-offs for waist circumference. Moreover, waist circumfer-
ence is used as only optimal component in ATP III. IDF criteria with waist circumference thresholds specific to 
Asian population (men 90 cm and women 80 cm) might be therefore more suitable for estimation of metabolic 
syndrome among adult Nepalese population.
Much of the health care priorities to date in low and middle income countries, including Nepal has been 
catering to infectious diseases and maternal and child health. A high burden of MetS as we demonstrated in our 
study and confirmed by other small studies from non-specialist hospital setting necessitates acknowledging the 
importance of reducing NCD risk factors at population level. The primary goal should be creating environment 
that facilitates greater physical activity and awareness regarding healthy dietary choices. In addition, the health 
systems need to be strengthened to reach the populations that are at risk for NCDs. Additionally, alternate models 
for service delivery and health promotion should be considered to reach unprivileged population with limited 
access to health care services. These may include mobilization of community health volunteers and mass media 
campaigns aimed at changing risky lifestyle behaviors.
Nationally, representative data are limited in Nepal and prevalence figures in the earlier studies were esti-
mated using non-comparable sampling design in a section of population. This study is based on a large national 
sample consisting of both urban and rural populations in Nepal. However, as in any cross-sectional study, we 
could not establish causality between metabolic syndrome and its determinants. The South Asian population 
have been shown to be genetically susceptible to central obesity and insulin resistance35. However, the absence 
of genetic studies in Nepal have limited our understanding of the role of genetic factors in the pathogenesis of 
metabolic syndrome among Nepalese adults. The STEPS survey did not include information on household wealth 
or monthly income of participants hence an important determinant of metabolic syndrome could not be assessed 
among Nepalese population in this study.
Conclusion
Our study demonstrates a high burden of MetS in Nepalese adults with ten percentage increment in prevalence 
across each age groups fifteen years apart. The prevalence peaked among those aged 45–69 years such as three 
in ten in this age-group had MetS. A substantial clustering of risk factors was evident with 80.7% having at least 
one risk factor. A triad of low HDL-C, abdominal obesity and high BP was the most prevalent (8.18%), followed 
by abdominal obesity, low HDL-C cholesterol and high triglycerides (8%). Female gender, urban, hill or terai 
resident were particularly at risk.
Methods
Study design and sampling technique. This is a secondary analysis carried out using Non-Communicable 
Diseases risk factors 2013 data. The detail methodology and report of the survey has been presented elsewhere36. 
In brief, the survey was a cross sectional study, carried out from January to June 2013, with aim to assesses the risk 
factors of NCDs at entire population level.
Un-weighted ATP III IDF
Yes 2,673 20.93 24.70
P-value <0.001 <0.001
BMI category
<25 2,773 8.76 6.85
25-<30 763 33.83 43.84
≥30 193 61.2 64.71
P-value <0.001 <0.001
Total 3,729 15.36 15.82
Table 3. Prevalence of metabolic syndrome by demographic and clinical risk factors.
Figure 2. Prevalence of the metabolic syndrome according to ATP III and IDF definitions.
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Firstly, out of the 921 Ilakas (an administrative unit at the sub-district level) in Nepal, 70 were selected, which 
were proportionately distributed across Nepal’s three ecological zones (Mountain, Hill and Terai/Plains) using 
probability proportionate to population size (PPS) which served as a primary sampling unit (PSU) of the study. 
ATP III Criteria IDF Criteria
OR 95%CI OR# 95%CI OR 95%CI OR# 95%CI
Age group
15–29 1 1 1 1
30–44 4.53 2.81–7.32** 3.04 1.84–5.03** 3.74 2.58–5.41** 2.07 1.31–3.25*
45–69 8.66 5.46–13.73** 7.08 4.26–11.78** 6.11 4.31–8.65** 4.52 2.91–7.03**
Gender
   Male 1 1 1
   Female 1.01 0.82–1.24 0.97 0.75–1.26 1.43 1.14–1.79* 1.44 1.05–1.97*
Level of education
No formal schooling 1 1 1
Primary 0.84 0.65–1.10 1.11 0.82–1.51 0.84 0.65–1.07 1.08 0.79–1.49
Secondary 0.84 0.62–1.13 1.53 1.07–2.19* 0.71 0.54–0.93* 1.11 0.76–1.63
Higher 0.57 0.41–0.80* 1.03 0.65–1.63 0.57 0.41–0.79* 0.90 0.57–1.41
Marital status
Never married 1 1
Currently married 5.5 2.37–12.79** 1.25 0.50–3.12 6.97 3.30–14.72** 1.72 0.73–4.08
Divorced/Widowed/Separated 7.37 2.98–18.21** 1.03 0.39–2.73 7.59 3.44–16.75** 1.12 0.44–2.85
Caste/ethnicity
Dalits 1 1 1 1
Disadvantaged Janajatis 0.85 0.55–1.31 0.79 0.48–1.33 0.73 0.46–1.14 0.58 0.34–1.01
Disadvantaged non-Dalit Terai caste groups 0.68 0.39–1.19 0.78 0.45–1.34 0.69 0.37–1.26 0.64 0.32–1.26
Religious minorities 1.87 0.87–4.01 1.99 0.76–5.18 0.94 0.33–2.74 0.65 0.16–2.63
Relatively advantaged Janajatis 1.66 0.97–2.84 0.73 0.42–1.28 1.50 0.88–2.59 0.65 0.36–1.19
Upper caste groups 1.06 0.70–1.61 0.76 0.48–1.20 0.98 0.63–1.52 0.61 0.36–1.06
Ecological zone
Mountain 1 1 1 1
Hill 1.66 0.89–3.10 1.04 0.49–2.18 3.82 2.00–7.31** 2.41 1.04–5.63*
Terai 1.02 0.56–1.87 0.75 0.36–1.55 2.99 1.57–5.70* 2.64 1.14–6.11*
Place of residence
Rural 1 1 1 1
Urban 1.97 1.44–2.71** 1.56 1.14–2.13* 2.02 1.48–2.76** 1.56 1.14–2.13*
Current smoking
No 1 1
Yes 0.87 0.64–1.20 0.76 0.51–1.13 0.68 0.50–0.92* 0.71 0.50–1.01
Harmful use of alcohol
No 1 1 1 1
Yes 1.45 0.54–3.93 1.80 0.46–7.03 0.54 0.20–1.41 0.69 0.21–2.28
Insufficient fruit and vegetable intake
No 1 1 1 1
Yes 1.24 0.47–3.23 2.21 0.75–6.50 0.86 0.30–2.49 1.24 0.42–3.63
Low physical activity
No 1 1 1 1
Yes 1.88 1.15–3.08* 1.48 0.89–2.47 1.25 0.74–2.10 0.93 0.54–1.59
Abnormal waist hip ratio
No 1 1 1
Yes 3.36 2.40–4.70** 2.50 1.79–3.50** 14.46 10.48–19.95** 8.18 5.93–11.29**
BMI category
<25 1 1 1 1
25–30 5.32 4.06–6.97** 3.74 2.79–5.02** 10.61 8.13–13.84** 7.82 5.78–10.78**
>30 16.42 10.84–24.87** 9.44 6.03–14.78** 24.92 16.02–38.77** 14.03 8.71–22.60**
Table 4. Univariate and multivariate analyses of demographic and clinical risk factors for metabolic syndrome. 
#Adjusted relative risk have been adjusted for all variables listed. *p < 0.05; **P < 0.001.
www.nature.com/scientificreports/
8ScIEntIFIc REPORTS |  (2018) 8:14995  | DOI:10.1038/s41598-018-33177-5
Secondly, three clusters, the wards (the smallest administrative units) were selected from each of the PSU using 
the PPS. A total of 210 clusters were selected served as secondary sampling unit of this study. Subsequently, using 
systematic sampling, twenty households per cluster were selected. Using Kish method, one participant in each 
household were selected from the eligible frame (15–69 years). A sample size of 4,200 was used to represent the 
adult target population aged 15–69 years in Nepal. In order to calculate the required sample size the prevalence 
of low fruit and vegetable consumption was considered 61.9%, absolute margin of error ±5%, design effect 1.5, 
response rate 80% and six domains (three age categories and two genders) were considered to obtain nationally 
representative sample. A detail algorithms of sample size calculation have presented elsewhere36.
Survey implementation. A total of 26 researchers divided into 2 teams were assigned for data collection. 
Each team was composed of field supervisor, medical laboratory technologist, laboratory technician one each, 
and ten enumerators having nursing, public health or paramedics background. Their major responsibility was to 
fill out the questionnaires, carry out physical measurements and collect blood samples. The laboratory technicians 
were assigned for cold chain maintenance, sample processing, and the recording and reporting of biochemical 
measurements carried out using wet methods. Medical laboratory technologists were responsible for examining 
and verifying glucose levels and the value of the lipid profile including sending a 10% blood sample to the refer-
ence laboratory for external quality control.
Variable Definition/measurements
Physical measurements
Height and weight were measured and body mass index (BMI) calculated as weight (kg.)/height (m2). Portable standard stature scale was used to 
measure height. Footwear (shoes, slippers, sandals) and hat were removed while measuring height. Respondents stood on a flat surface facing the 
interviewer with their feet together and heels against the backboard with knees straight. They were asked to look straight ahead and not tilt their head up, 
making sure that their eyes were at the same level as their ears. Height was recorded in centimetres.
Weight was measured with a portable digital weighing scale (Seca, Germany). The instrument was placed on a firm, flat surface. Participants were 
requested to remove their footwear and socks, wear light clothes, stand on the scale with one foot on each side of the scale, face forward, place arms at 
their side and wait until asked to step off. Waist and hip circumference was measured using constant tension tapes (Seca, Germany) in centimeters37.
Blood Pressure 
measurements
Blood pressure was measured with a digital, automated blood pressure monitor (OMRON digital device) with medium cuff. Before taking the 
measurements, participants were asked to sit quietly and rest for 15 minutes with legs uncrossed. Three readings of the systolic and diastolic blood 
pressure were obtained using standard protocol. Participants rested for three minutes between each reading. The mean of the second and third readings 
was calculated.
High blood pressure was defined as having systolic blood pressure ≥130 mm Hg and/or diastolic blood pressure ≥85 mm Hg during the study, or being 
previously diagnosed as having hypertension determined by sighting documentation such as a treatment record book or by the history of the participant 
taking medicine for high blood pressure.
Biochemical measurements
A separate mobile laboratory setting was used to collect biochemical data. The mobile laboratory contained all of the logistics and human resources 
required for the set up including a semi auto analyser and all of the chemicals required for blood glucose testing and lipid profile measurement. To 
ensure that the cold chain was maintained for the collected samples and for the preservation of the chemicals used for the tests, continuous electricity 
was ensured with an electric generator and refrigerator.
Participants were instructed to fast overnight for 12 hours and diabetic patients on medication were reminded to bring their medicine/insulin with them 
and take their medicine after providing the blood sample to measure fasting glucose. Wet (liquid) method was used to measure blood lipids. A venous 
blood sample (4 ml of blood) was taken using a flashback needle with an aseptic technique and kept in plain and fluoride treated tubes. Those samples 
were kept in an ice pack carrier and brought to the mobile laboratory within an hour. Biochemical measurements of blood glucose and lipids were done 
using semi-automated procedures (Bioanalyzer, Analyticon, Germany) and commercially available kits (Analyticon, Germany). Plasma glucose was 
estimated using the GOD-PAP (glucose oxidase/peroxidise – phenol-4-amenophenazone) method. Serum triglycerides were estimated using the GPO-
PAP (glycerol-3-phosphate oxidase/peroxidase-4-chlorophenol and 4-aminophenazone) method. HDL cholesterol was determined using the CHOD-
PAP (cholesteroloxidase/peroxidase – 4-phenol-aminoantipyrine) method36. External quality control of these biochemical investigations was performed 
by sending 10% of the samples to the nearest reference laboratory with standardized fully-automated procedures for biochemical measurement.
Metabolic syndrome [NCEP 
ATP III criteria]38
Any three of the five criteria below:
• Waist circumference: >102 cm (Male), >88 cm (Female).
• Fasting glucose ≥100 mg/dl or Rx.
• Triglycerides ≥150 mg/dl or Rx.
• HDL cholesterol: <40 mg/dl (Male), <50 mg/dl (Female); or Rx ≥130 mmHg systolic or ≥85 mmHg diastolic or Rx.
Metabolic syndrome [IDF 
criteria]38
Central obesity (waist circumference: ≥90 cm (Male), ≥80 cm (Female)) plus two of the following criteria below:
• Fasting glucose ≥100 mg/dl or Rx
• Triglycerides ≥150 mg/dl or Rx
• HDL cholesterol: <40 mg/dl (Male), <50 mg/dl (Female); or Rx ≥130 mmHg systolic or ≥85 mmHg diastolic or Rx
Current smoking Those who smoked in the past 30 days were considered as a current smoker.
Harmful Alcohol 
consumption
Detailed information on number of standard drinks consumed and frequency of consuming standard drinks in the last 30 days was obtained from 
current users. One standard drinks was considered as 10 grams of ethanol, the number of standard drinks was calculated using the amount consumed by 
participants.
Insufficient fruits and 
vegetable intake
Information on fruit and vegetables consumption in a typical week. Also, the number of servings of fruit and vegetables consumed on average per day. 
The amount of fruit and vegetables was measured using pictorial show cards and measuring cups (one standard serving of fruit or vegetables equals 80 
grams).
Low Physical activity
Global Physical Activity Questionnaire (GPAQ) was used to assess physical activities39. The GPAQ asks participants about activities for vigorous and 
moderate activity at work, and vigorous and moderate activity in leisure time and time spent sitting. Culturally relevant Show-cards with examples were 
used to classifying activities. Physical activity related to transport and recreation and time spent in sedentary behaviour were also assessed. Physical 
activity related to transport included travel to work or market by walking or using a bicycle. Recreational activity included two types of activities based 
on severity, i.e., vigorous and moderate. Vigorous recreational activity was defined as any recreational activity that causes a large increase in heart rate 
and breathing; for example, games such as football, fast swimming and rapid cycling. Ten minutes of such activity was considered as involvement in 
vigorous recreational activity. Moderate recreational activity was defined as any kind of recreational activity that causes a moderate increase in heart rate 
and breathing; examples include yoga and playing basketball. Sedentary behaviour was defined as a behaviour where an individual spends time sitting at 
a desk, sitting with friends, travelling in a car, bus or train, reading a book, and so on. Analysis and categorization followed existing guidelines40,41 and the 
low physical activities were categorized to those who did not meet the criteria for vigorous and moderate intensity activities.
Abnormal waist to hip 
ratio42 Abnormal waist to hip ratio is defined as a waist–hip ratio >0.90 for males and >0.85 for females.
Table 5. Showing the definition of variables used in the study.
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A week-long training was organised in the two weeks prior to the beginning of data collection. The training 
was led by a STEPS team from WHO headquarters, Geneva and WHO SEARO, New Delhi. The local investiga-
tor team also joined the STEPS team as trainers. Prior to the training, the data collection team were oriented on 
the tools to be used to collect the data. Training focused on interview techniques, sampling process, household 
and individual selection, the use of the different kinds of templates and forms in the survey, the use and care of 
PDAs, a detailed explanation of the questionnaire and the technique to be used for physical measurements. The 
supervisors were also trained on downloading data from the PDAs as well as the troubleshooting of minor issues 
with the PDAs.
Overall, field operation and quality control was responsibility of field supervisor including coordinate with 
respective authorities at the field level, ensure completion of sampling frames, and select 20 households from each 
cluster. Also, the field supervisors were responsible for aggregating the data from individual PDAs to their laptop 
and forwarding them to the centre via email or by handing them over to the investigators.
Definition of variables. The dependent variable in this analysis was occurrence of metabolic syndrome. The 
indicators analysed in this study are defined in Table 5. Two major predictor variables were included: individual 
characteristics: age in years (15–29, 30–44 and 45–69), gender (male and female), education (no formal school-
ing, primary, secondary and higher level), marital status (never married, currently married and divorced/wid-
owed/separated) and caste/ethnicity, and community characteristics: ecological zone (mountain, hill and terai/
plains) and place of residence (urban and rural) in this analysis.
Data processing and analysis. In order to obtain nationally representative estimates, the sampling weights 
were used. Chi-square statistics was used to assess the difference in risk factors by gender. To reflect clustering 
within individuals, we considered the number of risk factors that each participant had at the time of the sur-
vey (from 0 to 5) and examined the mean number and 95%CIs of risk factors by covariates. We examined the 
independent effects of covariates on risk factor clustering within individuals by modeling a multivariate Poisson 
regression model, with the number of risk factors as the dependent variable. All the analysis carried out was using 
complex survey design; wards were considered as cluster and ecological zones as strata.
Univariate and multivariate logistic regression were used to test associations between predictors and outcome 
variables using Stata SE 14. Adjusted odd ratio (AOR) was calculated using multiple logistic regression, with all 
predictors (age, gender, education, marital status, ecological zone and place of residence) included simultaneously 
in the model in order to assess the predictors of MetS. A p-value < 0.05 was considered as statistically significant.
Ethical Considerations. This study was approved by the ethical review board of the Nepal Health Research 
Council. An informed written consent was obtained from all the participants. For the participants under the age 
of 18 years, informed consent from parent/legal guardian was obtained. Waste generated during the laboratory 
procedures was properly disinfected using aseptic techniques and safely disposed as per protocol. Blood samples 
were discarded after the biochemical measurements.
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